Seller record · Telehealth service

formidableMD

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The weight management page refers only to reputable 503A compounding pharmacies, and the answers to preferred compounding pharmacies. 2 more criteria also fail; see the table below.

At a glance

formidableMDTelehealth service

5/8criteria passed

Price: Semaglutide from $169, tirzepatide from $199, plus a $199 first visit
Sells: compounded semaglutide, compounded tirzepatide, and 3 more
FDA letters: None on file

Visit formidableMD See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Florida telehealth practice for women in midlife offering medical weight management with brand-name or compounded semaglutide and tirzepatide, hormone therapy and wellness coaching, led by a board-certified family physician. Treatment follows a paid video visit, and prescribing is offered in four states.

Operating entity No legal entity name appears in the footer, on the home page, in the terms of use, in the HIPAA privacy notice or in the payment and billing agreement.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	formidableMD's weight management page; formidableMD's FAQ; formidableMD's our story page
S2	Prescription gating	PASS	formidableMD's weight management page; formidableMD's refund policy; formidableMD's FAQ
S3	Pharmacy identification	FAIL	formidableMD's weight management page; formidableMD's FAQ
S4	Compounding disclosure	FAIL	formidableMD's website; formidableMD's weight management page; formidableMD's FAQ; formidableMD's terms of service page
S5	Analytical documentation	FAIL	formidableMD's weight management page
S6	Business address	PASS	formidableMD's website; formidableMD's terms of service page
S7	Price disclosure	PASS	formidableMD's weight management page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEvery initial weight management appointment is a one-on-one video visit with a qualified provider, the answers say the providers are board-certified physicians and nurse practitioners, and the about page names a board-certified family physician as medical director.Source: formidableMD's weight management page; formidableMD's FAQ; formidableMD's our story page.

S2PASSThe weight management page says the patient schedules an appointment and completes an intake questionnaire, and that medication is considered only during a one-on-one video visit with a provider. The payment taken at booking is a visit fee that excludes medication.Source: formidableMD's weight management page; formidableMD's refund policy; formidableMD's FAQ.

S3FAILNo filling pharmacy is named. The weight management page refers only to reputable 503A compounding pharmacies, and the answers to preferred compounding pharmacies.Source: formidableMD's weight management page; formidableMD's FAQ.

S4FAILThe home page and the weight management page offer FDA-approved and compounded GLP-1 options side by side, and no page, including the answers and the terms, states that compounded medications are not FDA-approved.Source: formidableMD's website; formidableMD's weight management page; formidableMD's FAQ; formidableMD's terms of service page.

S5FAILNo certificate of analysis or lot document is published. The weight management page says every product is tested for sterility, potency and purity, with no document behind the claim.Source: formidableMD's weight management page.

S6PASS450 State Road 13 N, Suite 106, Saint Johns, FL 32259, printed as the corporate address in the footer of every page. The terms name St. Johns County, Florida, for court relief.Source: formidableMD's website; formidableMD's terms of service page.

S7PASSCompounded semaglutide priced by strength from $169 (1 mg) to $269 (10 mg) and compounded tirzepatide from $199 (10 mg) to $319 (40 mg), with a $199 initial consultation and $99 follow-up visits, and no membership fee.Source: formidableMD's weight management page.

S8PASSNo FDA warning letter names formidableMD, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, brand-name GLP-1 medications, hormone replacement therapy, lab panels.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit formidableMD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.